STAFF PROFILE
Professor Steven Bozinovski
Position:
Professor
College / Portfolio:
STEM College
School / Department:
STEM|Health and Biomedical Sciences
Phone:
+61399256674
Campus:
Bundoora West
Contact me about:
Research supervision
- Dobric, A.,De Luca, S.,Spencer, S.,Bozinovski, S.,Saling, M.,McDonald, C.,Vlahos, R. (2022). Novel pharmacological strategies to treat cognitive dysfunction in chronic obstructive pulmonary disease In: Pharmacology and Therapeutics, 233, 1 - 19
- Alhayyani, S.,McLeod, L.,Bozinovski, S.,Jenkins, B. J., et al, . (2022). Oncogenic dependency on STAT3 serine phosphorylation in KRAS mutant lung cancer In: Oncogene, 41, 809 - 823
- Wang, H.,Tumes, D.,Hercus, T.,Yip, K.,Aloe, C.,Vlahos, R.,Lopez, A.,Wilson, N.,Owczarek, C.,Bozinovski, S. (2022). Blocking the human common beta subunit of the GM-CSF, IL-5 and IL-3 receptors markedly reduces hyperinflammation in ARDS models In: Cell Death and Disease, 13, 1 - 11
- Mou, K.,Chan, S.,Brassington, K.,Dobric, A.,De Luca, S.,Seow, H.,Selemidis, S.,Bozinovski, S.,Vlahos, R. (2022). Influenza A Virus-Driven Airway Inflammation may be Dissociated From Limb Muscle Atrophy in Cigarette Smoke-Exposed Mice In: Frontiers in Pharmacology, 13, 1 - 18
- Aujla, S.,Aloe, C.,Vannitamby, A.,Wang, H.,Vlahos, R.,Selemidis, S.,Bozinovski, S., et al, . (2022). Programmed Death-Ligand 1 Copy Number Loss in NSCLC Associates With Reduced Programmed Death-Ligand 1 Tumor Staining and a Cold Immunophenotype In: Journal of Thoracic Oncology, 17, 675 - 687
- Brassington, K.,Selemidis, S.,Bozinovski, S.,Vlahos, R. (2022). Chronic obstructive pulmonary disease and atherosclerosis: common mechanisms and novel therapeutics In: Clinical Science, 136, 405 - 423
- Aloe, C.,Wang, H.,Vlahos, R.,Irving, L.,Steinfort, D.,Bozinovski, S. (2021). Emerging and multifaceted role of neutrophils in lung cancer In: Translational Lung Cancer Research, 10, 2806 - 2818
- Bozinovski, S.,Vannitamby, A.,Rangamuwa, K.,Aujla, S.,Wang, H.,Aloe, C.,Irving, L.,Leong, T.,Steinfort, D. (2021). Integrating endobronchial ultrasound bronchoscopy with molecular testing of immunotherapy biomarkers in non-small cell lung cancer In: Translational Lung Cancer Research, 10, 2779 - 2787
- Rangamuwa, K.,Leong, T.,Bozinovski, S.,Christie, M.,John, T.,Antippa, P.,Irving, L.,Steinfort, D. (2021). Increase in tumour PD-L1 expression in non-small cell lung cancer following bronchoscopic thermal vapour ablation In: Translational Lung Cancer Research, 10, 2858 - 2864
- Rangamuwa, K.,Leong, T.,Weeden, C.,Asselin-Labat, M.,Bozinovski, S.,Christie, M.,John, T.,Antippa, P.,Irving, L.,Steinfort, D. (2021). Thermal ablation in non-small cell lung cancer: A review of treatment modalities and the evidence for combination with immune checkpoint inhibitors In: Translational Lung Cancer Research, 10, 2842 - 2857
- Silicosis – Harnessing new ideas to conquer the re-emergence of an ancient lung disease - The SHIELD Study (Administered by University of Queensland). Funded by: Medical Research Future Fund from (2022 to 2025)
- Novel mRNA therapeutic strategies for reprogramming tumour associated macrophages in lung cancer. Funded by: mRNA Victorian Medical Research Acceleration Fund from (2022 to 2024)
- Targeting oxidant-dependent pathways to treat skeletal muscle wasting in COPD. Funded by: National Health and Medical Research Council (NHMRC) Project Grants 2017 (for funding commencing in 2018) from (2018 to 2023)
- FPR2 is a therapeutic target in lung cancer. Funded by: National Health and Medical Research Council (NHMRC) Project Grants 2017 (for funding commencing in 2018) from (2018 to 2022)
- Novel pharmacological strategies to treat cognitive dysfunction in COPD. Funded by: National Health and Medical Research Council (NHMRC) Project Grants 2017 (for funding commencing in 2018) from (2018 to 2022)
4 PhD Current Supervisions6 PhD Completions and 1 Masters by Research Completions
Asthma, Chronic obstructive pulmonary disease, Lung inflamation, Oxidative stress, Respiratory infections, Emphysema